Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-05-19 @ 9:56 PM
Study NCT ID:
NCT04803318
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2021-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ZZ3TKI-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None